Profarma Distribuidora de Produtos Farmaceuticos SA operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Profarma Distribuidora de Produtos Farmaceuticos SA with three other
drug stores in Latin America:
Corporativo Fragua, SAB de CV
of MEXICO
(2019
sales of 61.88 billion Mexican Pesos [US$2.47 billion]
of which 71%
was Medical),
Dimed SA Distribuidora do Medicamentos
(2.72 billion Brazilian Reals [US$509.19 million]
of which 90%
was Retail), and
Raia Drogasil SA
(17.57 billion Brazilian Reals [US$3.28 billion]
of which 46%
was Drugs: Brand).
Sales Analysis.
Profarma Distribuidora de Produtos Farmaceuticos SA reported sales of 4.80 billion Brazilian Reals (US$897.27 million)
for the
year ending
December of 2019.
This
represents
an
increase of 12.4%
versus 2018, when the company's sales were 4.27 billion Brazilian Reals.
Sales at Profarma Distribuidora de Produtos Farmaceuticos SA have increased during each of the previous five years
(and since 2014, sales have increased a total of 39%).
Sales of Pharmaceutical Distribution saw an increase
of
16.1% in 2019, from
3.88 billion Brazilian Reals to 4.50 billion Brazilian Reals.
Not all segments of Profarma Distribuidora de Produtos Farmaceuticos SA experienced an increase in sales in 2019:
sales of Pharmaceutical Retail fell 2.5% to 1.13 billion Brazilian Reals.